Related Experiment Videos
[Mumps meningitis and mumps vaccination (author's transl)]
Abstract:
Mumps meningitis (MM) is the most frequent inflammatory disease of the central nervous system in children. It occurs twice as often in boys as in girls. Usually it is mild; encephalitic signs are found only in 2-3% of the cases. Even here persistent neurological signs are rare, but psychological alterations are found in about 20% of the cases. 40% of all MM cases occur in children of school age necessitating absence from school for four weeks at last. The frequency of MM makes it a financial problem too. In Viennese hospitals 4.2 million Austrian Schillings were spent yearly for hospitalization of children with MM, on average, during the years 1971-1975. The vaccination of all Viennese children born in a single year (18,000) against mumps would require an outlay of only 2.8 million Austrian Schillings. Wide-spread routine vaccination against mumps is indicated, therefore, not only for medical, but for social and economic reasons as well.
Insights
Mumps meningitis (MM) is a common childhood CNS inflammatory disease, more frequent in boys. Routine mumps vaccination is medically, socially, and economically recommended due to its high incidence and associated costs.
Area of Science:
- Pediatrics
- Neurology
- Infectious Diseases
Context:
- Mumps meningitis (MM) is the most common inflammatory central nervous system disease in children.
- It affects boys twice as often as girls and is usually mild, with severe neurological sequelae being rare.
Purpose:
- To evaluate the medical, social, and economic impact of mumps meningitis in children.
- To assess the cost-effectiveness of routine mumps vaccination.
Summary:
- MM affects approximately 2-3% of mumps cases, with psychological alterations noted in 20% of affected children.
- 40% of cases occur in school-aged children, leading to at least four weeks of school absence.
- Hospitalization costs for MM in Viennese hospitals averaged 4.2 million Austrian Schillings annually between 1971-1975.
Impact:
- Routine mumps vaccination for all children born in a year (18,000) costs 2.8 million Austrian Schillings.
- Widespread mumps vaccination is indicated for medical, social, and economic reasons.
- Vaccination can significantly reduce healthcare expenditures and societal burden associated with mumps meningitis.